AOL Money & Finance

Dyncorp posts

Feed

The week in preview: DynCorp, Joy Global, Shanda and more

Much of the attention this week will no doubt be on how the impending General Motors (NYSE: GM) bankruptcy will shake out, as well as the usual economic concerns: Has the housing market bottomed? Will oil prices keep rising? Is the employment situation getting any better? And so on (see highlights of the economic calendar below).

What probably won't get much attention are quarterly earnings, as the earnings season for this quarter winds down. But there are a few reports that analysts surveyed by Thomson Reuters have high hopes for.

Continue reading The week in preview: DynCorp, Joy Global, Shanda and more

The 52-Week high club

Several stocks made new 52-week highs today on large volume.

Adams Respiratory Therapeutics, Inc. (NASDAQ: ARXT): Personal care products maker Reckitt Benckiser made a buy-out offer. Shares moved up to $59.30 against a 52-week low of $27.25.

MGI Pharma, Inc. (NASDAQ: MOGN): Japanese pharmaceutical maker Eisai will buy the company. Shares rose to $40.23 compared to 52-week low of $16.98.

Millennium Pharmaceuticals, Inc. (NASDAQ: MLNM): This company's late stage cancer drug shows promise. The company hit $16.62, well up from 52-week low of $9.49.

Canadian Solar Inc. (NASDAQ: CSIQ): A new contract for peer LDK Solar Co., Ltd. (NYSE: LDK) pulled the entire sector higher. Canadian Solar hit $24.83 against a 52-week low of $6.50.

DynCorp International Inc. (NYSE: DCP): A new Army contract boosted shares to $25.97, compared with a 52-week low of $13.51.

Douglas A. McIntyre is an editor at 247wallst.com.

Analyst upgrades 6-07-07: Semiconductor sector, DGX and FNM

MOST NOTEWORTHY: The semiconductor sector, Quest Diagnostics (NYSE: DGX) and Federal National Mortgage Association (NYSE: FNM) were today's noteworthy upgrades:
  • Bernstein upgraded the semiconductor sector to Overweight form Market Weight on expectations that utilization will rise starting in Q2. The firm upgraded ASML Holding NV (NASDAQ: ASML) to Outperform from Market Perform and Infineon Technologies (NYSE: IFX) to Market Perform from Underperform.
  • UBS upgraded Quest Diagnostics to Buy from Neutral, citing Laboratory Corporation Of America Holdings' (NYSE: LH) contract renewal with Cigna HealthCare, which should ease concerns regarding deteriorating pricing.
  • Fannie Mae was upgraded to Outperform from Market Perform at Friedman Billings, citing improving fundamentals, better business mix and the possibility the company reports current financials in the next 12-18 months.
OTHER UPGRADES:

Symbol Lookup
IndexesChangePrice
DJIA-154.4810,309.92
NASDAQ-37.612,138.44
S&P 500-19.141,091.49

Last updated: November 28, 2009: 01:01 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance